Nel ASA's Calendar Sets the Stage for a Crucial Autumn — But the Clock Is Ticking on Multiple Fronts

Nel ASA confirms Q3 2026 results for Oct 15, but faces CEO transition, legal settlement impact, and JPMorgan price target cut.

Investors in the Norwegian hydrogen group now have firm dates to mark in their diaries, with the company's financial calendar for 2026 and 2027 confirming that third-quarter numbers will land on 15 October 2026, followed by the fourth-quarter report on 18 February 2027. Yet the run-up to that first disclosure is shaping up to be anything but quiet, with a leadership transition, a recent legal settlement and persistent analyst caution all converging on the same narrow window.

The share, currently trading at €0.1956, sits roughly 46 percent below its 52-week high of €0.3655 reached in May — a gap that underscores just how far sentiment has travelled in a matter of months. Technical indicators paint a mixed picture: the relative strength index stands at 43, suggesting neither oversold nor overbought conditions, while the stock has drifted 2.2 percent since the second-quarter figures were released.

The Second-Quarter Hangover

Much of the current scepticism traces back to the numbers published in July, which remain the reference point for how the market values the company. Revenue from customer contracts fell 12 percent year-on-year to NOK 153 million, while the EBITDA loss widened sharply from NOK 86 million to NOK 155 million. The bottom line showed a net loss of NOK 189 million, a figure that absorbed a NOK 70 million charge tied to the settlement with Iwatani Corporation of America — a long-running legal dispute over hydrogen refuelling that was resolved roughly three weeks ago.

Against that backdrop, the order book offers a more encouraging counterpoint. New orders in the second quarter reached NOK 230 million, a marked improvement on the previous quarter, though the total backlog of NOK 1.21 billion remained slightly below the year-earlier level. The company also ended the period with liquidity of approximately NOK 1.328 billion, a cushion that has been reinforced by EU Innovation Fund backing of up to €135 million, originally awarded in October 2024.

A Leadership Vacuum and a Technology Bet

Complicating the operational picture is the impending departure of Håkon Volldal, who announced his resignation as president and CEO in June and is now midway through a six-month transition period. The packaging group Elopak confirmed roughly three weeks ago that Volldal will take the helm there no later than 1 January 2027, leaving Nel with the task of steadying the ship while simultaneously searching for a successor.

On the technology front, the company has been pushing forward regardless. In May, Nel announced the commercial launch of its new generation of pressurised alkaline electrolysers, a project supported by that EU Innovation Fund grant and aimed at expanding production capacity at its Herøya site in Norway to 1 gigawatt per year.

Analyst Caution Mounts

The market's mood has not been helped by a series of downgrades. JPMorgan cut its price target on Nel from NOK 2.90 to NOK 1.80 roughly three weeks ago, maintaining a "Neutral" rating while citing weak operational momentum and a lack of catalysts for a sustained turnaround. The automated service StockInvest.us has gone further, moving its assessment from "Hold" to "Sell Candidate" after the stock declined 6.79 percent over ten trading days — though that particular call is model-driven and reflects price dynamics rather than fundamental analysis.

What October Must Deliver

With the calendar now locked in, the 15 October report becomes the next decisive test. The key question for investors is whether the strong order intake from the second quarter can begin converting into actual revenue, or whether the margin weakness that has defined recent quarters will persist. The February 2027 release, meanwhile, will offer the first proper insight into how the leadership change is shaping strategic direction.

For a company navigating a CEO exit, a settled legal dispute and a technology ramp-up all at once, the coming months will demand execution — and the market will be watching closely to see whether the backlog finally starts translating into the top line.